Premium Industrial News

Pfizer/BioNTech Promise Extra 75 Million COVID-19 Vaccine Doses for EU

Pfizer/BioNTech Promise Extra 75 Million COVID-19 Vaccine Doses for EU

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 888 Words

GALWAY, IRELAND--February 9, 2021--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--The Pfizer/BioNTech duo has completed the manufacturing upgrades needed to overcome recent European delays in the production of its COVID-19 vaccine and has promised an extra 75 million doses by Spring.

Within this article: Details production upgrades for extra vaccine rollout, plants, deals with rivals to boost production

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now!(All Fields Required)

Subscription Type:

  • Pay-Per-Article - $5.95
  • Annual Premium News Subscription - $365.00
Pricing Help?